10 Charts, 1 Growth Story: Join us for an Exclusive Webinar LIVE on April 23rd @6pm
Here is the latest financial fact sheet of J.B.Chemicals. For more details, see the J.B.Chemicals quarterly results and J.B.Chemicals share price and chart. For a sector overview, read our pharmaceuticals sector report.
% ch | % | 2.2 |
No. of shares | m | 84.80 |
% ch week | % | 6.0 |
% ch 1-mth | % | 8.1 |
% ch 12-mth | % | 128.1 |
52 week H/L | Rs | 1,323.1/539.6 |
No. of Mths Year Ending |
12 Mar-14* |
12 Mar-15* |
12 Mar-16* |
12 Mar-17* |
12 Mar-18* |
5-Yr Chart Click to enlarge
|
---|
J.B.CHEMICALS EQUITY SHARE DATA | |||||||
---|---|---|---|---|---|---|---|
High | Rs | 142 | 258 | 318 | 404 | 363 | |
Low | Rs | 73 | 129 | 200 | 231 | 255 | |
Sales per share (Unadj.) | Rs | 120.6 | 134.9 | 148.0 | 161.3 | 169.1 | |
Earnings per share (Unadj.) | Rs | 7.3 | 11.8 | 19.1 | 21.7 | 16.6 | |
Diluted earnings per share | Rs | 7.3 | 11.8 | 19.1 | 21.7 | 16.4 | |
Cash flow per share (Unadj.) | Rs | 10.6 | 16.4 | 23.9 | 27.3 | 23.4 | |
Dividends per share (Unadj.) | Rs | 3.00 | 14.00 | 0.50 | 1.00 | 2.00 | |
Adj. dividends per share | Rs | 3.00 | 14.00 | 0.50 | 1.00 | 1.97 | |
Dividend yield (eoy) | % | 2.8 | 7.2 | 0.2 | 0.3 | 0.6 | |
Book value per share (Unadj.) | Rs | 123.1 | 117.3 | 128.9 | 160.8 | 172.5 | |
Adj. book value per share | Rs | 123.0 | 117.3 | 129.0 | 160.8 | 170.0 | |
Shares outstanding (eoy) | m | 84.73 | 84.81 | 84.82 | 84.82 | 83.57 | |
Bonus/Rights/Conversions | ESOP | ESOP | - | - | BB | ||
Price / Sales ratio | x | 0.9 | 1.4 | 1.7 | 2.0 | 1.8 | |
Avg P/E ratio | x | 14.8 | 16.3 | 13.6 | 14.6 | 18.6 | |
P/CF ratio (eoy) | x | 10.1 | 11.8 | 10.8 | 11.6 | 13.2 | |
Price / Book Value ratio | x | 0.9 | 1.6 | 2.0 | 2.0 | 1.8 | |
Dividend payout | % | 41.3 | 118.3 | 2.6 | 4.6 | 12.0 | |
Avg Mkt Cap | Rs m | 9,079 | 16,381 | 21,951 | 26,913 | 25,827 | |
No. of employees | `000 | 2.5 | 2.2 | 2.7 | 3.5 | 3.8 | |
Total wages/salary | Rs m | 1,437 | 1,596 | 1,841 | 2,173 | 2,511 | |
Avg. sales/employee | Rs Th | 4,120.4 | 5,302.2 | 4,590.9 | 3,902.8 | 3,747.4 | |
Avg. wages/employee | Rs Th | 579.3 | 739.4 | 673.4 | 619.9 | 665.7 | |
Avg. net profit/employee | Rs Th | 248.0 | 465.3 | 592.1 | 525.9 | 367.8 |
J.B.CHEMICALS INCOME DATA | |||||||
---|---|---|---|---|---|---|---|
Net Sales | Rs m | 10,219 | 11,442 | 12,551 | 13,683 | 14,135 | |
Other income | Rs m | 377 | 109 | 542 | 502 | 366 | |
Total revenues | Rs m | 10,596 | 11,551 | 13,093 | 14,185 | 14,501 | |
Gross profit | Rs m | 1,485 | 1,792 | 2,055 | 2,324 | 2,178 | |
Depreciation | Rs m | 280 | 386 | 412 | 472 | 570 | |
Interest | Rs m | 62 | 59 | 96 | 54 | 35 | |
Profit before tax | Rs m | 1,520 | 1,456 | 2,088 | 2,299 | 1,940 | |
Minority Interest | Rs m | 0 | 0 | 0 | 0 | 0 | |
Prior Period Items | Rs m | 21 | 0 | 0 | 0 | 0 | |
Extraordinary Inc (Exp) | Rs m | -645 | 0 | 0 | 0 | 0 | |
Tax | Rs m | 281 | 451 | 469 | 455 | 552 | |
Profit after tax | Rs m | 615 | 1,004 | 1,619 | 1,844 | 1,387 | |
Gross profit margin | % | 14.5 | 15.7 | 16.4 | 17.0 | 15.4 | |
Effective tax rate | % | 18.5 | 31.0 | 22.5 | 19.8 | 28.5 | |
Net profit margin | % | 6.0 | 8.8 | 12.9 | 13.5 | 9.8 |
J.B.CHEMICALS BALANCE SHEET DATA | |||||||
---|---|---|---|---|---|---|---|
Current assets | Rs m | 9,807 | 9,009 | 7,778 | 7,949 | 10,470 | |
Current liabilities | Rs m | 2,763 | 4,598 | 4,358 | 2,812 | 2,749 | |
Net working cap to sales | % | 68.9 | 38.6 | 27.2 | 37.5 | 54.6 | |
Current ratio | x | 3.5 | 2.0 | 1.8 | 2.8 | 3.8 | |
Inventory Days | Days | 48 | 48 | 55 | 53 | 55 | |
Debtors Days | Days | 84 | 84 | 80 | 71 | 78 | |
Net fixed assets | Rs m | 3,569 | 3,838 | 5,713 | 6,010 | 5,811 | |
Share capital | Rs m | 169 | 170 | 170 | 170 | 167 | |
"Free" reserves | Rs m | 10,037 | 9,531 | 10,547 | 13,467 | 14,248 | |
Net worth | Rs m | 10,428 | 9,949 | 10,937 | 13,637 | 14,416 | |
Long term debt | Rs m | 5 | 4 | 0 | 0 | 0 | |
Total assets | Rs m | 13,510 | 14,872 | 15,574 | 16,740 | 17,649 | |
Interest coverage | x | 25.4 | 25.5 | 22.8 | 43.8 | 56.6 | |
Debt to equity ratio | x | 0 | 0 | 0 | 0 | 0 | |
Sales to assets ratio | x | 0.8 | 0.8 | 0.8 | 0.8 | 0.8 | |
Return on assets | % | 5.0 | 7.2 | 11.0 | 11.3 | 8.1 | |
Return on equity | % | 5.9 | 10.1 | 14.8 | 13.5 | 9.6 | |
Return on capital | % | 9.2 | 15.2 | 20.0 | 17.3 | 13.7 | |
Exports to sales | % | 54.3 | 50.6 | 48.7 | 0 | 0 | |
Imports to sales | % | 8.4 | 8.8 | 7.1 | 0 | 0 | |
Exports (fob) | Rs m | 5,546 | 5,787 | 6,115 | 0 | 0 | |
Imports (cif) | Rs m | 861 | 1,006 | 889 | 0 | 0 | |
Fx inflow | Rs m | 5,605 | 5,833 | 6,169 | 6,369 | 6,164 | |
Fx outflow | Rs m | 1,569 | 1,388 | 1,285 | 1,497 | 1,334 | |
Net fx | Rs m | 4,037 | 4,445 | 4,884 | 4,872 | 4,829 |
J.B.CHEMICALS CASH FLOW | |||||||
---|---|---|---|---|---|---|---|
From Operations | Rs m | -140 | 1,267 | 1,397 | 2,011 | 1,231 | |
From Investments | Rs m | -1,425 | -1,119 | -320 | -453 | -208 | |
From Financial Activity | Rs m | 120 | -14 | -1,196 | -1,838 | -595 | |
Net Cashflow | Rs m | -1,444 | 134 | -102 | -280 | 427 |
Share Holding
|
Company Information
|
CHM: Durga Dass Chopra | COMP SEC: M. C. Mehta | YEAR OF INC: 1976 | BSE CODE: 506943 | FV (Rs): 2 | DIV YIELD (%): 0.2 |
Read: J.B.CHEMICALS 2017-18 Annual Report Analysis
More Pharmaceuticals Company Fact Sheets: AMAR REMEDIES AJANTA PHARMA STRIDES PHARMA SCIENCE CIPLA ALEMBIC
Compare J.B.CHEMICALS With: AMAR REMEDIES AJANTA PHARMA STRIDES PHARMA SCIENCE CIPLA ALEMBIC
Compare J.B.CHEMICALS With: MYLAN (US) ACTAVIS (US) ADCOCK INGRAM (S. Africa) TEVA PHARMA (Israel)
Indian share markets witnessed volatile trading activity throughout the day today and ended lower.
For the quarter ended December 2019, J.B.CHEMICALS has posted a net profit of Rs 622 m (up 34.1% YoY). Sales on the other hand came in at Rs 4 bn (up 9.3% YoY). Read on for a complete analysis of J.B.CHEMICALS's quarterly results.
For the quarter ended March 2019, J.B.CHEMICALS has posted a net profit of Rs 422 m (up 91.2% YoY). Sales on the other hand came in at Rs 4 bn (up 18.9% YoY). Read on for a complete analysis of J.B.CHEMICALS's quarterly results.
More Views on NewsAjit Dayal on how India's vaccine strategy will impact the markets.
Narayana Murthy was one of the first unicorn founders to get the backing of this entity...
There is no stopping this 11-bagger stock from significant upside.
In this video, I'll you what I think is the real reason behind yesterday's market crash.
Those who don't learn from financial history are doomed to lose their money.
More